Machine Learning

A new trial for a cell therapy targeting a rare eye disease offers hope, driven by a patient-advocate's journey and with potential to treat common AMD.

The soundtracking giant's new desktop app lets creators drag and drop music directly to their timeline, cutting production time and boosting flow.

At ECR 2026, Subtle Medical showcases AI that boosts existing scanners, expands into CT, and promises faster, clearer diagnostics for patients.

Greenwich LifeSciences' Phase III trial for its GLSI-100 immunotherapy is enrolling patients faster than ever, with early data echoing past success.

A new partnership combines intelligent routing and a NaaS platform to solve AI's biggest network challenges, targeting the booming Asia-Pacific market.

At QuanCon 2026, Quantexa unveiled a landmark partnership with Moody’s, positioning Decision Intelligence as the core of next-gen AI organizations.

Post-listing, the Swiss HealthTech firm pushes for US market expansion and European reimbursement, streamlining its focus on AI-powered brain health.

A novel CRISPR-based therapy safely targets deadly E. coli in the gut, showing promise in the fight against antibiotic resistance and for protecting cancer patients.

With a pivotal trial for pancreatic cancer looming, Immuneering will detail its novel 'Deep Cyclic Inhibitor' platform and strategy to investors.

With soaring revenue and new EU approval, Senseonics is taking control of its sales, but rising costs raise questions about its path to profitability.

Entrepreneur Daniel Gestetner discusses resilience, a $1B exit, and why true success isn't about winning at all costs in a revealing new podcast.

Team Velocity's new AI assistant is moving beyond chatbots, enabling real-time transactions on dealer sites and delivering major boosts in lead generation.

At MWC, Lifecycle Software unveils NEXUS® IQ, an AI platform promising to cut telco churn by 40% and transform raw customer data into profit.

Consark.ai's new Noa platform uses autonomous agents to execute complex accounting, promising a shift from human preparation to AI-led execution.

At MWC26, Huawei Cloud launched its Industry AI Foundry, a new hybrid cloud, and an AI coding agent, doubling down on AI to solve real-world problems.

A potential first-in-class therapy for two untreatable neurological diseases, co-discovered by AI and robotics, has begun human testing in a major milestone.

HTC's VIVERSE launches a global art contest, leveraging web technology to let anyone create and view immersive 3D art without needing a VR headset.

A promising oral therapy for Huntington's disease has been deemed eligible for accelerated review in Australia, offering new hope for a breakthrough.

An Israeli startup claims its 'Artificial Expert Intelligence' autonomously achieved a 3.6x speedup over a decade of human-engineered NVIDIA code.

A new board certification in Disaster Medicine will equip physicians across 14 specialties to lead during crises, enhancing healthcare system resilience.